Tocilizumab for the Treatment of Mevalonate Kinase Deficiency

Case Reports in Pediatrics
Nadia K RafiqPaul A Brogan

Abstract

Mevalonate kinase deficiency (MKD) is a severe autoinflammatory disease caused by recessive mutations in MVK resulting in reduced function of the enzyme mevalonate kinase, involved in the cholesterol/isoprenoid pathway. MKD presents with periodic episodes of severe systemic inflammation, poor quality of life, and life-threatening sequelae if inadequately treated. We report the case of a 12-year-old girl with MKD and severe autoinflammation that was resistant to IL-1 and TNF-α blockade. In view of this, she commenced intravenous tocilizumab (8 mg/kg every 2 weeks), a humanised monoclonal antibody targeting the IL-6 receptor (IL-6R) that binds to membrane and soluble IL-6R, inhibiting IL-6-mediated signaling. She reported immediate cessation of fever and marked improvement in her energy levels following the first infusion; after the fifth dose, she was in complete clinical and serological remission, now sustained for 24 months. This is one of the first reported cases of a child with MKD treated successfully with tocilizumab and adds to the very limited experience of this treatment for MKD. IL-6 blockade could therefore be an important addition to the armamentarium for the treatment of this rare monogenic autoinflammatory disease.

References

May 26, 2006·Orphanet Journal of Rare Diseases·Dorothea Haas, Georg F Hoffmann
Dec 12, 2007·Handbook of Experimental Pharmacology·N Nishimoto, T Kishimoto
Jun 29, 2012·Rheumatology·Caroline GaleottiIsabelle Koné-Paut
Jul 4, 2012·Annals of the Rheumatic Diseases·Nienke Ter HaarUNKNOWN Paediatric Rheumatology International Trials Organisation (PRINTO) and the Eurofever/Eurotraps Projects
Dec 21, 2012·The New England Journal of Medicine·Fabrizio De BenedettiUNKNOWN PRCSG
Feb 25, 2014·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Hiba M ShendiJohn David Edgar
Mar 12, 2015·Orphanet Journal of Rare Diseases·Linda Rossi-SemeranoUNKNOWN MAIL1 (Maladies Auto-inflammatoires et Anti-IL-1) study Group on behalf of CRI (Club Rhumatisme et Inflammation)
Jun 26, 2015·Annals of the Rheumatic Diseases·Nienke M ter HaarJasmin B Kuemmerle-Deschner
Oct 31, 2015·BMJ Case Reports·Anne MustersSander W Tas
May 5, 2016·Pediatric Rheumatology Online Journal·Shumin Zhang
Oct 28, 2016·Arthritis & Rheumatology·Nienke M Ter HaarUNKNOWN Paediatric Rheumatology International Trials Organisation and Eurofever Project
Jul 6, 2016·Immunology and Cell Biology·Julie JurczylukMichael J Rogers
Aug 9, 2016·The Application of Clinical Genetics·Leslie A Favier, Grant S Schulert

❮ Previous
Next ❯

Citations

Jul 4, 2020·Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Società Italiana Di Dermatologia E Sifilografia·Isabelle Koné-Paut, Perrine Dusser

❮ Previous
Next ❯

Methods Mentioned

BETA
geranylgeranylation
ESR
GTPase

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
Hiba M ShendiJohn David Edgar
The New England Journal of Medicine
Elizabeth J Hager, K Michael Gibson
© 2022 Meta ULC. All rights reserved